Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Summer;14(3):490-494.
doi: 10.22088/cjim.14.3.490.

Occurrence of butyrylcholinesterase polymorphisms in patients undergoing surgery in Slovakia

Lukáš Čuchráč  1 , Marta MydlárováBlaščáková  2 , Jozef Firment  1 , Jana Šimonová  1 , Bernasovská Jarmila  2 , Janka Vašková  3
Affiliations

Occurrence of butyrylcholinesterase polymorphisms in patients undergoing surgery in Slovakia

Lukáš Čuchráč et al. Caspian J Intern Med. 2023 Summer.

Abstract

Background: Post-operative residual curarization is a persisting problem, characterized by muscle fatigue, exhaustion or paresis, caused by the use of neuromuscular blocking agents with prolonged postoperative effect. Genetically, determined changes in cholinesterase activity can be a major reason for persistent muscle blockade after administration of muscle relaxants.

Methods: Regarding the subsistence of polymorphisms in the plasma cholinesterase gene causing change in enzyme activity and metabolism of applied drugs, we investigated the frequency of two polymorphisms known to reduce its activity significantly in patients undergoing surgery.

Results: Primary results show a relatively high occurrence of plasma cholinesterase K risk allele (18.75%).

Conclusion: Characterization of the lacking information about genetic background of changes in plasma cholinesterase activity within Slovakia may allow for easier decision-making in clinical practice when selecting alternative neuromuscular blocking and also reversal agents.

Keywords: Butyrylcholinesterase; Cholinesterase; Neuromuscular blocker; Polymorphism; Residual curarization.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Brull SJ, Kopman AF. Current status of neuromuscular reversal and monitoring: challenges and opportunities. Anesthesiology. 2017;126:173–90. - PubMed
    1. Weiser TG, Regenbogen SE, Thompson KD, et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet . 2008;372:139–44. - PubMed
    1. Butterly A, Bittner EA, George E, et al. Postoperative residual curarization from intermediate-acting neuromuscular blocking agents delays recovery room discharge. Brit J Anaesth. 2010;105:304–9. - PubMed
    1. Plaud B, Debaene B, Donati F, Marty J. Residual Paralysis after Emergence from Anesthesia. Anesthesiology. 2010;112:1013–22. - PubMed
    1. Murphy GS, Brull SJ. Residual neuromuscular block: lessons unlearned Part I: definitions, incidence, and adverse physiologic effects of residual neuromuscular block. AnesthAnalg. 2010;111:120–8. - PubMed

LinkOut - more resources